Marex Group’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Sell
2,100,000
-5,770,000
-73% -$27M 0.05% 173
2026
Q1
$27.9M Buy
7,870,000
+970,000
+14% +$3.97M 0.18% 108
2025
Q4
$32.6M Buy
+6,900,000
New +$30.7M 0.21% 99
2025
Q2
Sell
-75,504
Closed -$197K 834
2025
Q1
$197K Buy
+75,504
New +$244K ﹤0.01% 578

Other funds holding MSOS

Marex Group's MSOS Position: Q2 2026 in Review

Marex Group reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 73% in Q2 2026, selling an estimated $27M and leaving 2,100,000 shares worth $10.7M. The position accounts for 0.05% of the portfolio, ranked #173.

Marex Group first reported a position in MSOS in Q1 2025 and has held it in 4 quarters since. The position peaked at $32.6M in Q4 2025. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Marex Group held 2,100,000 shares of AdvisorShares Pure US Cannabis ETF worth $10.7M as of Q2 2026.
  • Marex Group sold 5,770,000 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $27M.
  • AdvisorShares Pure US Cannabis ETF made up 0.05% of Marex Group's portfolio in Q2 2026, its #173 holding.
  • Marex Group first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2025 and has held it in 4 quarters since.
  • Marex Group's AdvisorShares Pure US Cannabis ETF position peaked at $32.6M in Q4 2025.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.